Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Seretide/Advair

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Seretide/Advair was produced by GlaxoSmithKline.

Could formulary intelligence be your brand differentiator?

Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.

GSK forges ahead with its dynamic COPD and asthma portfolio

GSK forges ahead with its dynamic COPD and asthma portfolio For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.

GSK seeks EU approval for Trelegy in adult asthma patients

GSK seeks EU approval for Trelegy in adult asthma patients GSK’s respiratory business has been hit with the loss of patent protection for its COPD blockbuster Seretide/Advair (fluticasone propionate/salmeterol) – Trelegy is GSK’s answer to the increased competition

GSK considers more divestments to help R&D push

GSK considers more divestments to help R&D push She said it was encouraging that in the year that generic competition really bit hard into sales of GSK’s longstanding respiratory blockbuster Advair/Seretide (fluticasone propionate/salmeterol), the group was

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus

GSK divests travel vaccines to Bavarian Nordic as part of strategic refocus The revamp at GSK was needed in large part due to generic competition to its blockbuster respiratory treatment Advair.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics